Precipio Gross Margin 2010-2024 | PRPO
Current and historical gross margin for Precipio (PRPO) over the last 10 years. The current gross profit margin for Precipio as of June 30, 2024 is %.
| Precipio Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-06-30 |
$0.02B |
$0.01B |
43.75% |
| 2024-03-31 |
$0.02B |
$0.01B |
37.50% |
| 2023-12-31 |
$0.02B |
$0.01B |
37.50% |
| 2023-09-30 |
$0.01B |
$0.01B |
35.71% |
| 2023-06-30 |
$0.01B |
$0.00B |
27.27% |
| 2023-03-31 |
$0.01B |
$0.00B |
33.33% |
| 2022-12-31 |
$0.01B |
$0.00B |
37.50% |
| 2022-09-30 |
$0.01B |
$0.00B |
37.50% |
| 2022-06-30 |
$0.01B |
$0.00B |
50.00% |
| 2022-03-31 |
$0.01B |
$0.00B |
50.00% |
| 2021-12-31 |
$0.01B |
$0.00B |
37.50% |
| 2021-09-30 |
$0.01B |
$0.00B |
25.00% |
| 2021-06-30 |
$0.01B |
$0.00B |
12.50% |
| 2021-03-31 |
$0.01B |
0 |
0.00% |
| 2020-12-31 |
$0.01B |
0 |
0.00% |
| 2020-09-30 |
$0.01B |
0 |
0.00% |
| 2020-06-30 |
$0.00B |
0 |
0.00% |
| 2020-03-31 |
$0.00B |
0 |
0.00% |
| 2019-12-31 |
$0.00B |
0 |
0.00% |
| 2019-09-30 |
$0.00B |
0 |
0.00% |
| 2019-06-30 |
$0.00B |
0 |
0.00% |
| 2019-03-31 |
$0.00B |
0 |
0.00% |
| 2018-12-31 |
$0.00B |
0 |
0.00% |
| 2018-09-30 |
$0.00B |
0 |
0.00% |
| 2018-06-30 |
$0.00B |
0 |
0.00% |
| 2018-03-31 |
$0.00B |
0 |
0.00% |
| 2017-12-31 |
$0.00B |
0 |
0.00% |
| 2017-09-30 |
$0.00B |
$0.00B |
100.00% |
| 2017-06-30 |
$0.00B |
$0.00B |
100.00% |
| 2017-03-31 |
$0.00B |
$0.00B |
50.00% |
| 2016-12-31 |
$0.00B |
$0.00B |
50.00% |
| 2016-09-30 |
$0.00B |
0 |
0.00% |
| 2016-06-30 |
$0.00B |
0 |
0.00% |
| 2016-03-31 |
$0.00B |
0 |
nan% |
| 2015-12-31 |
$0.00B |
0 |
0.00% |
| 2015-09-30 |
$-0.02B |
$-0.01B |
53.33% |
| 2015-06-30 |
$-0.01B |
$-0.01B |
54.55% |
| 2015-03-31 |
$-0.00B |
$-0.00B |
100.00% |
| 2014-12-31 |
$0.00B |
$-0.00B |
-200.00% |
| 2014-09-30 |
$0.02B |
$0.01B |
34.78% |
| 2014-06-30 |
$0.03B |
$0.01B |
30.77% |
| 2014-03-31 |
$0.03B |
$0.01B |
34.62% |
| 2013-12-31 |
$0.03B |
$0.01B |
37.04% |
| 2013-09-30 |
$0.03B |
$0.01B |
35.71% |
| 2013-06-30 |
$0.03B |
$0.01B |
41.38% |
| 2013-03-31 |
$0.03B |
$0.01B |
45.16% |
| 2012-12-31 |
$0.03B |
$0.01B |
45.16% |
| 2012-09-30 |
$0.03B |
$0.02B |
51.52% |
| 2012-06-30 |
$0.03B |
$0.02B |
51.52% |
| 2012-03-31 |
$0.03B |
$0.02B |
53.13% |
| 2011-12-31 |
$0.03B |
$0.02B |
56.25% |
| 2011-09-30 |
$0.03B |
$0.02B |
53.57% |
| 2011-06-30 |
$0.02B |
$0.01B |
54.17% |
| 2011-03-31 |
$0.02B |
$0.01B |
47.62% |
| 2010-12-31 |
$0.02B |
$0.01B |
47.37% |
| 2010-09-30 |
$0.02B |
$0.01B |
47.62% |
| 2010-06-30 |
$0.02B |
$0.01B |
50.00% |
| 2010-03-31 |
$0.02B |
$0.01B |
54.55% |
| 2009-12-31 |
$0.02B |
$0.01B |
54.55% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.009B |
$0.015B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
